Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1539125
PUBLISHER: KBV Research | PRODUCT CODE: 1539125
Europe Anxiety Disorders And Depression Treatment Market Size, Share & Trends Analysis Report By Indication (Anxiety and Depression) By Drugs, By Distribution Channel, By Country and Growth Forecast, 2024 - 2031
PUBLISHED:
PAGES: 133 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Europe Anxiety Disorders And Depression Treatment Market would witness market growth of 3.1% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Anxiety Disorders And Depression Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,029.4 million by 2031. The UK market is exhibiting a CAGR of 2.3% during (2024 - 2031). Additionally, The France market would exhibit a CAGR of 3.9% during (2024 - 2031).
The development of new and more effective antidepressants and anxiolytics, with improved safety profiles and fewer side effects, has expanded treatment options for patients. Adopting digital mental health solutions, including mobile therapy and mood-tracking apps, has made treatment more accessible and convenient.
Additionally, many healthcare providers now include mental health screenings as part of routine medical check-ups, which has led to early identification and intervention for anxiety and depression. Programs focusing on early intervention and preventive care have increased the adoption of treatments before conditions become severe.
The rising cases of depression and anxiety among European workers drive companies to implement or expand workplace mental health programs. This creates increased demand for mental health resources, employee assistance programs (EAPs), and counselling services designed to support affected employees. As per the European Council, in 2022, 27% of workers in Europe experienced stress, depression, or anxiety. Additionally, there was a 22% rise in loneliness across the E.U. following the COVID-19 pandemic.
Based on Indication, the market is segmented into Anxiety and Depression. Based on Drugs, the market is segmented into Antidepressants, Anxiolytics, Anticonvulsants, Noradrenergic Agents, and Atypical Antipsychotics. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Pfizer Inc.
- GlaxoSmithKline PLC (GSK)
- Merck & Co., Inc.
- Eli Lilly And Company
- AstraZeneca PLC
- Bristol-Myers Squibb Company
- Johnson & Johnson
- AbbVie Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
Europe Anxiety Disorders And Depression Treatment Market Report Segmentation
By Indication
- Anxiety
- Depression
By Drugs
- Antidepressants
- Anxiolytics
- Anticonvulsants
- Noradrenergic Agents
- Atypical Antipsychotics
By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Anxiety Disorders And Depression Treatment Market, by Indication
- 1.4.2 Europe Anxiety Disorders And Depression Treatment Market, by Drugs
- 1.4.3 Europe Anxiety Disorders And Depression Treatment Market, by Distribution Channel
- 1.4.4 Europe Anxiety Disorders And Depression Treatment Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter Five Forces Analysis
Chapter 4. Europe Anxiety Disorders And Depression Treatment Market by Indication
- 4.1 Europe Anxiety Market by Country
- 4.2 Europe Depression Market by Country
Chapter 5. Europe Anxiety Disorders And Depression Treatment Market by Drugs
- 5.1 Europe Antidepressants Market by Country
- 5.2 Europe Anxiolytics Market by Country
- 5.3 Europe Anticonvulsants Market by Country
- 5.4 Europe Noradrenergic Agents Market by Country
- 5.5 Europe Atypical Antipsychotics Market by Country
Chapter 6. Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 6.1 Europe Retail Pharmacies Market by Country
- 6.2 Europe Hospital Pharmacies Market by Country
- 6.3 Europe Online Pharmacies Market by Country
Chapter 7. Europe Anxiety Disorders And Depression Treatment Market by Country
- 7.1 Germany Anxiety Disorders And Depression Treatment Market
- 7.1.1 Germany Anxiety Disorders And Depression Treatment Market by Indication
- 7.1.2 Germany Anxiety Disorders And Depression Treatment Market by Drugs
- 7.1.3 Germany Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.2 UK Anxiety Disorders And Depression Treatment Market
- 7.2.1 UK Anxiety Disorders And Depression Treatment Market by Indication
- 7.2.2 UK Anxiety Disorders And Depression Treatment Market by Drugs
- 7.2.3 UK Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.3 France Anxiety Disorders And Depression Treatment Market
- 7.3.1 France Anxiety Disorders And Depression Treatment Market by Indication
- 7.3.2 France Anxiety Disorders And Depression Treatment Market by Drugs
- 7.3.3 France Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.4 Russia Anxiety Disorders And Depression Treatment Market
- 7.4.1 Russia Anxiety Disorders And Depression Treatment Market by Indication
- 7.4.2 Russia Anxiety Disorders And Depression Treatment Market by Drugs
- 7.4.3 Russia Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.5 Spain Anxiety Disorders And Depression Treatment Market
- 7.5.1 Spain Anxiety Disorders And Depression Treatment Market by Indication
- 7.5.2 Spain Anxiety Disorders And Depression Treatment Market by Drugs
- 7.5.3 Spain Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.6 Italy Anxiety Disorders And Depression Treatment Market
- 7.6.1 Italy Anxiety Disorders And Depression Treatment Market by Indication
- 7.6.2 Italy Anxiety Disorders And Depression Treatment Market by Drugs
- 7.6.3 Italy Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.7 Rest of Europe Anxiety Disorders And Depression Treatment Market
- 7.7.1 Rest of Europe Anxiety Disorders And Depression Treatment Market by Indication
- 7.7.2 Rest of Europe Anxiety Disorders And Depression Treatment Market by Drugs
- 7.7.3 Rest of Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel
Chapter 8. Company Profiles
- 8.1 Pfizer, Inc.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Regional & Segmental Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
- 8.2 GlaxoSmithKline PLC (GSK)
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 SWOT Analysis
- 8.3 Merck & Co., Inc.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 SWOT Analysis
- 8.4 Eli Lilly And Company
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 Research & Development Expenses
- 8.4.5 SWOT Analysis
- 8.5 AstraZeneca PLC
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 SWOT Analysis
- 8.6 Bristol-Myers Squibb Company
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Regional Analysis
- 8.6.4 Research & Development Expenses
- 8.6.5 SWOT Analysis
- 8.7 Johnson & Johnson
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental & Regional Analysis
- 8.7.4 Research & Development Expenses
- 8.7.5 SWOT Analysis
- 8.8 AbbVie, Inc.
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Regional Analysis
- 8.8.4 Research & Development Expense
- 8.8.5 SWOT Analysis
- 8.9 Sanofi S.A.
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental and Regional Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 SWOT Analysis
- 8.10. Takeda Pharmaceutical Company Limited
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Regional Analysis
- 8.10.4 Research & Development Expense
- 8.10.5 SWOT Analysis
LIST OF TABLES
- TABLE 1 Europe Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
- TABLE 2 Europe Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
- TABLE 3 Europe Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
- TABLE 4 Europe Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
- TABLE 5 Europe Anxiety Market by Country, 2020 - 2023, USD Million
- TABLE 6 Europe Anxiety Market by Country, 2024 - 2031, USD Million
- TABLE 7 Europe Depression Market by Country, 2020 - 2023, USD Million
- TABLE 8 Europe Depression Market by Country, 2024 - 2031, USD Million
- TABLE 9 Europe Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
- TABLE 10 Europe Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
- TABLE 11 Europe Antidepressants Market by Country, 2020 - 2023, USD Million
- TABLE 12 Europe Antidepressants Market by Country, 2024 - 2031, USD Million
- TABLE 13 Europe Anxiolytics Market by Country, 2020 - 2023, USD Million
- TABLE 14 Europe Anxiolytics Market by Country, 2024 - 2031, USD Million
- TABLE 15 Europe Anticonvulsants Market by Country, 2020 - 2023, USD Million
- TABLE 16 Europe Anticonvulsants Market by Country, 2024 - 2031, USD Million
- TABLE 17 Europe Noradrenergic Agents Market by Country, 2020 - 2023, USD Million
- TABLE 18 Europe Noradrenergic Agents Market by Country, 2024 - 2031, USD Million
- TABLE 19 Europe Atypical Antipsychotics Market by Country, 2020 - 2023, USD Million
- TABLE 20 Europe Atypical Antipsychotics Market by Country, 2024 - 2031, USD Million
- TABLE 21 Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 22 Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 23 Europe Retail Pharmacies Market by Country, 2020 - 2023, USD Million
- TABLE 24 Europe Retail Pharmacies Market by Country, 2024 - 2031, USD Million
- TABLE 25 Europe Hospital Pharmacies Market by Country, 2020 - 2023, USD Million
- TABLE 26 Europe Hospital Pharmacies Market by Country, 2024 - 2031, USD Million
- TABLE 27 Europe Online Pharmacies Market by Country, 2020 - 2023, USD Million
- TABLE 28 Europe Online Pharmacies Market by Country, 2024 - 2031, USD Million
- TABLE 29 Europe Anxiety Disorders And Depression Treatment Market by Country, 2020 - 2023, USD Million
- TABLE 30 Europe Anxiety Disorders And Depression Treatment Market by Country, 2024 - 2031, USD Million
- TABLE 31 Germany Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
- TABLE 32 Germany Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
- TABLE 33 Germany Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
- TABLE 34 Germany Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
- TABLE 35 Germany Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
- TABLE 36 Germany Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
- TABLE 37 Germany Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 38 Germany Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 39 UK Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
- TABLE 40 UK Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
- TABLE 41 UK Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
- TABLE 42 UK Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
- TABLE 43 UK Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
- TABLE 44 UK Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
- TABLE 45 UK Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 46 UK Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 47 France Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
- TABLE 48 France Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
- TABLE 49 France Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
- TABLE 50 France Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
- TABLE 51 France Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
- TABLE 52 France Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
- TABLE 53 France Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 54 France Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 55 Russia Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
- TABLE 56 Russia Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
- TABLE 57 Russia Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
- TABLE 58 Russia Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
- TABLE 59 Russia Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
- TABLE 60 Russia Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
- TABLE 61 Russia Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 62 Russia Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 63 Spain Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
- TABLE 64 Spain Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
- TABLE 65 Spain Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
- TABLE 66 Spain Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
- TABLE 67 Spain Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
- TABLE 68 Spain Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
- TABLE 69 Spain Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 70 Spain Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 71 Italy Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
- TABLE 72 Italy Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
- TABLE 73 Italy Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
- TABLE 74 Italy Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
- TABLE 75 Italy Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
- TABLE 76 Italy Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
- TABLE 77 Italy Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 78 Italy Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 79 Rest of Europe Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
- TABLE 80 Rest of Europe Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
- TABLE 81 Rest of Europe Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
- TABLE 82 Rest of Europe Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
- TABLE 83 Rest of Europe Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
- TABLE 84 Rest of Europe Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
- TABLE 85 Rest of Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 86 Rest of Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 87 Key Information - Pfizer, Inc.
- TABLE 88 Key Information - GlaxoSmithKline PLC
- TABLE 89 Key Information - Merck & Co., Inc.
- TABLE 90 Key Information - Eli Lilly And Company
- TABLE 91 Key Information - AstraZeneca PLC
- TABLE 92 Key Information - Bristol-Myers Squibb Company
- TABLE 93 Key Information - Johnson & Johnson
- TABLE 94 Key information - AbbVie, Inc.
- TABLE 95 Key Information - Sanofi S.A.
- TABLE 96 Key Information - Takeda Pharmaceutical Company Limited
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.